[1-ethoxysilatrane--an inhibitor of the development of experimental atherosclerotic lesion of the aorta].
D000818:Animals; D001013:Aorta, Thoracic / Q000378:metabolism; D001018:Aortic Diseases / Q000188:drug therapy* / Q000378:metabolism; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism; D001643:Bridged Bicyclo Compounds / Q000627:therapeutic use*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds / Q000627:therapeutic use*; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D004353:Drug Evaluation, Preclinical; D050356:Lipid Metabolism; D017646:Organosilicon Compounds; D011817:Rabbits; D012825:Silicon / Q000627:therapeutic use*; D013997:Time Factors
D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds; D002791:Cholesterol, Dietary; D017646:Organosilicon Compounds; C015503:silatrane; C042292:1-ethoxysilatrane; D012825:Silicon
1-étoksisilatran--ingibitor razvitiia éksperimental'nogo ateroskleroticheskogo porazheniia aorty.